Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase-mediated event.
Open Access
- 1 October 2001
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 21 (10) , 1656-1661
- https://doi.org/10.1161/hq1001.096640
Abstract
LY 294002 (80 μmol/L), an inhibitor of phosphoinositide 3-kinase, was used to investigate the involvement of this enzyme in the insulin-mediated regulation of very low density lipoprotein (VLDL) apolipoprotein B (apoB) output from cultured rat hepatocytes. Newly synthesized apoB was pulse-labeled with [ 35 S]methionine and was then allowed to assemble, via an intermediate precursor stage, into mature VLDL during subsequent chase periods. Brefeldin A (BFA, 0.2 μg/mL) was used to discriminate between the role of insulin in the regulation of the early, compared with the later, events of VLDL assembly, including apoB degradation. Insulin (78 nmol/L), when present during the pulse-labeling and subsequent chase periods, inhibited the secretion of apoB-100 and apoB-48 as VLDL by 53% and 56%, respectively. Degradation of both was concomitantly increased. Secretion of high density lipoprotein apoB, derived from VLDL precursors, was relatively unaffected under these conditions, as was the net synthesis of apoB-100 and apoB-48. The presence of BFA during the pulse-labeling period and subsequent chase period prevented the maturation of VLDL in the insulin-treated and the non–insulin-treated cells. BFA was then removed, allowing the maturation of VLDL to proceed. Removal of insulin at this stage reversed the overall inhibitory effect of insulin. Furthermore, when insulin remained present during this period, the simultaneous presence of LY 294002 also reversed the inhibitory effect of insulin on VLDL apoB output and abolished the increase in apoB degradation. The results suggest that insulin signaling via phosphoinositide 3-kinase inhibited the maturation phase of VLDL assembly by preventing bulk lipid transfer to a VLDL precursor, thus enhancing the degradation of apoB. There was no inhibition of the conversion of newly synthesized apoB into the VLDL precursor form.Keywords
This publication has 23 references indexed in Scilit:
- ADP-ribosylation Factor 1 and Its Activation of Phospholipase D Are Important for the Assembly of Very Low Density LipoproteinsJournal of Biological Chemistry, 2000
- Inactivation of microsomal triglyceride transfer protein impairs the normal redistribution but not the turnover of newly synthesized glycerolipid in the cytosol, endoplasmic reticulum and Golgi of primary rat hepatocytesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1999
- Human ADP-ribosylation Factor-activated Phosphatidylcholine-specific Phospholipase D Defines a New and Highly Conserved Gene FamilyJournal of Biological Chemistry, 1995
- Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.Journal of Clinical Investigation, 1995
- Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARFNature, 1992
- Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: Evidence for membrane cycling from Golgi to ERCell, 1989
- Hepatic Production of VLDL-Triglycerides. Dependence of Portal Substrate and Insulin ConcentrationHormone and Metabolic Research, 1980
- Evidence that a separate particle containing B-apoprotein is present in high-density lipoproteins from perfused rat liverMetabolism, 1977
- Subcellular localization of B apoprotein of plasma lipoproteins in rat liver.The Journal of cell biology, 1976